Meier Jens, Müller Markus M, Lauscher Patrick, Sireis Walid, Seifried Erhard, Zacharowski Kai
Department of Anesthesiology and Intensive Care Medicine, Eberhard Karls University, Tübingen, Germany.
Transfus Med Hemother. 2012 Apr;39(2):98-103. doi: 10.1159/000337187. Epub 2012 Mar 19.
Although the transfusion of red blood cells (RBCs) is safer than ever regarding infections, it is still associated with several adverse reactions and therefore should only be used on the basis of evidence-based triggers. However, prevention of RBC transfusion and subsequent substitution of blood losses with acellular solutions will inevitably result in dilutional anemia. Acute dilutional anemia can be compensated by the body over a wide range of hemoglobin concentrations without a critical restriction of tissue oxygenation. On the other hand, chronic anemia is known to be a potent cause of morbidity and mortality. As a consequence, the impact of perioperative anemia on mortality is difficult to describe, because anemia, as well as the transfusion of RBCs, can influence the clinical outcome. The resulting 'Gordian knot' cannot be cut easily, and this circumstance forces clinical physicians to make a daily trade-off between transfusion-associated and anemia-associated risks. This review focuses on the physiology of oxygen transport, the hazards of acute anemia, the hazards of RBC transfusion, and the literature putting these problems into perspective.
尽管就感染而言,输注红细胞(RBC)比以往任何时候都更安全,但它仍与多种不良反应相关,因此仅应在基于循证触发因素的基础上使用。然而,预防RBC输血并随后用无细胞溶液替代失血将不可避免地导致稀释性贫血。急性稀释性贫血在广泛的血红蛋白浓度范围内可由身体代偿,而不会对组织氧合产生严重限制。另一方面,慢性贫血是已知的发病和死亡的重要原因。因此,围手术期贫血对死亡率的影响难以描述,因为贫血以及RBC输血都会影响临床结果。由此产生的“戈尔迪之结”难以轻易解开,这种情况迫使临床医生每天都要在输血相关风险和贫血相关风险之间进行权衡。本综述重点关注氧运输的生理学、急性贫血的危害、RBC输血的危害以及将这些问题纳入考量的文献。